Article
Microdermabrasion effectively rejuvenates the face without downtime or pain
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
FDA Approves Dupilumab, First and Only Targeted Medicine for Bullous Pemphigoid
Derm Dispatch: Advocating for Skin and Nail Health to Spread Melanoma Awareness
Daily Derm Times: June 19, 2025
Derm Dispatch: Discussing Early Detection and Education With a Melanoma Survivor
VALIANT Survey Shows High Rates of Depression in Patients with Vitiligo
Social Media Significantly Influences Attitudes, Behaviors Toward Skin Health